These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Polymyopathy and hereditary cardiomyopathy in the Syrian hamster. Selective inhibition of myocardial lesions]. Jasmin G; Bajusz E Ann Anat Pathol (Paris); 1973; 18(1):49-65. PubMed ID: 4146098 [No Abstract] [Full Text] [Related]
4. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line. Jasmin G; Proschek L Muscle Nerve; 1982 Jan; 5(1):20-5. PubMed ID: 7057801 [TBL] [Abstract][Full Text] [Related]
12. [Myocardial lesion in collagen diseases]. Rozhold O; Vojácek K Acta Univ Palacki Olomuc Fac Med; 1982; 102():267-76. PubMed ID: 6242579 [No Abstract] [Full Text] [Related]
13. New skeletal myopathy and cardiomyopathy associated with a missense mutation in MYH7. Darin N; Tajsharghi H; Ostman-Smith I; Gilljam T; Oldfors A Neurology; 2007 Jun; 68(23):2041-2. PubMed ID: 17548557 [No Abstract] [Full Text] [Related]
14. [Familial disposition for toxic rhabdomyolysis with myocardial involvement (author's transl)]. Schmidt RE; Vogel J; Gullotta F; Vogel F; Bechtelsheimer H Dtsch Med Wochenschr; 1981 Oct; 106(44):1458-62. PubMed ID: 7297434 [No Abstract] [Full Text] [Related]
15. [Unusual phenotype of myopathy associated with a new PNPLA2 mutation]. Jousserand G; Streichenberger N; Petiot P Med Sci (Paris); 2016 Nov; 32 Hors série n°2():10-11. PubMed ID: 27869069 [No Abstract] [Full Text] [Related]
17. [A new disease model: hereditary non-vascular myocardial degeneration with heart failure]. Bajusz E; Lossnitzer K Munch Med Wochenschr; 1968 Aug; 110(31):1756-68. PubMed ID: 5755400 [No Abstract] [Full Text] [Related]
18. [Hereditary cardiomyopathies: a review. Mutation of structural proteins a common cause of hereditary cardiomyopathy]. Sjöberg G; Kostareva A; Sejersen T Lakartidningen; 2005 Mar 14-20; 102(11):845-7, 850-3. PubMed ID: 15835520 [TBL] [Abstract][Full Text] [Related]
19. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. Heydemann A; McNally EM Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047 [TBL] [Abstract][Full Text] [Related]